Profund Advisors’s Gossamer Bio GOSS Stock Holding History

Profund Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-116,503	Closed	-$361K	–	1168
2025 Q4	$361K	Buy	+116,503	New	+$332K	0.01%	748

Other funds holding GOSS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Profund Advisors's GOSS Position: Q1 2026 in Review

Profund Advisors sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 116,503 shares — an estimated $361K sold.

Profund Advisors first reported a position in GOSS in Q4 2025 and held it in 1 quarter. The position peaked at $361K in Q4 2025. 185 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

Profund Advisors reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
Profund Advisors sold 116,503 Gossamer Bio shares in Q1 2026, an estimated $361K.
Profund Advisors first reported a position in Gossamer Bio in Q4 2025 and held it in 1 quarter.
Profund Advisors's Gossamer Bio position peaked at $361K in Q4 2025.
185 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.